Researchers sought to determine an effective approach to predict postembolization fever in patients undergoing TACE.

Fractal Analytics has filed its red herring prospectus (RHP) for INR 2,833.9 Cr IPO, marking a near 42% cut from the ...

Meesho’s shares continued to slide for the second straight session today after the company reported a sharp widening of ...

SoftTech Engineers Limited, a trusted name in technology-driven solutions for infrastructure and construction management has been awarded a prestigious contract worth INR 17.16 Crore by the Airports ...

By unifying data into a single backbone, the digital thread accelerates processes along the value chain to enable growth, ...

Nord Security invests over $100 million annually in R&D, with significant resources directed toward team expansion and ...

India: As India’s business landscape is reshaped by AI adoption, digital transformation, and increasing organisational complexity, the expectations from managers ...

Founded in 2017 and headquartered in Dubai, Zero&One is a leading regional cloud consultancy. The company holds nine AWS ...

PALISADE-4 Phase 3 Trial of fasedienol for acute treatment of Social Anxiety Disorder proceeding, with topline results from the randomized portion of the trial expected in the first half of 2026SOUTH ...

The Expanding Universe of CNC Applications and Market Drivers The demand for sophisticated CNC solutions is fueled by several ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.

Coursera, Inc. (NYSE:COUR) Q4 2025 Earnings Call Transcript February 5, 2026 Coursera, Inc. misses on earnings expectations.